1. Home
  2. LITB vs INTS Comparison

LITB vs INTS Comparison

Compare LITB & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITB
  • INTS
  • Stock Information
  • Founded
  • LITB 2007
  • INTS 2012
  • Country
  • LITB Singapore
  • INTS United States
  • Employees
  • LITB N/A
  • INTS N/A
  • Industry
  • LITB Catalog/Specialty Distribution
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LITB Consumer Discretionary
  • INTS Health Care
  • Exchange
  • LITB Nasdaq
  • INTS Nasdaq
  • Market Cap
  • LITB 32.7M
  • INTS 30.8M
  • IPO Year
  • LITB N/A
  • INTS 2023
  • Fundamental
  • Price
  • LITB $1.78
  • INTS $1.30
  • Analyst Decision
  • LITB
  • INTS Strong Buy
  • Analyst Count
  • LITB 0
  • INTS 3
  • Target Price
  • LITB N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • LITB 102.7K
  • INTS 37.8K
  • Earning Date
  • LITB 05-27-2025
  • INTS 05-08-2025
  • Dividend Yield
  • LITB N/A
  • INTS N/A
  • EPS Growth
  • LITB N/A
  • INTS N/A
  • EPS
  • LITB N/A
  • INTS N/A
  • Revenue
  • LITB $255,287,000.00
  • INTS N/A
  • Revenue This Year
  • LITB N/A
  • INTS N/A
  • Revenue Next Year
  • LITB N/A
  • INTS N/A
  • P/E Ratio
  • LITB N/A
  • INTS N/A
  • Revenue Growth
  • LITB N/A
  • INTS N/A
  • 52 Week Low
  • LITB $0.91
  • INTS $1.27
  • 52 Week High
  • LITB $6.00
  • INTS $5.28
  • Technical
  • Relative Strength Index (RSI)
  • LITB 53.73
  • INTS 22.77
  • Support Level
  • LITB $1.65
  • INTS $1.78
  • Resistance Level
  • LITB $2.12
  • INTS $1.94
  • Average True Range (ATR)
  • LITB 0.22
  • INTS 0.17
  • MACD
  • LITB -0.04
  • INTS -0.03
  • Stochastic Oscillator
  • LITB 25.00
  • INTS 4.10

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: